Similar articles

• Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

  Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Zarogoulidis P, et al. Eur J Clin Pharmacol. 2012 May;68(5):479-503. doi: 10.1007/s00228-011-1161-x. Epub 2011 Nov 22. Eur J Clin Pharmacol. 2012. PMID: 22105373 Review.
• Anti-inflammatory therapy in cystic fibrosis.

  Dinwiddie R. Dinwiddie R. J Cyst Fibros. 2005 Aug;4 Suppl 2:45-8. doi: 10.1016/j.jcf.2005.05.010. J Cyst Fibros. 2005. PMID: 16005266 Review.
• Non! to non-steroidal anti-inflammatory therapy for inflammatory lung disease in cystic fibrosis (at least at the moment).

  Bush A, Davies J. Bush A, et al. J Pediatr. 2007 Sep;151(3):228-30. doi: 10.1016/j.jpeds.2007.06.019. J Pediatr. 2007. PMID: 17719925 No abstract available.
• Targeting inflammation in cystic fibrosis.

  Kieninger E, Regamey N. Kieninger E, et al. Respiration. 2010;79(3):189-90. doi: 10.1159/000264605. Epub 2009 Dec 2. Respiration. 2010. PMID: 19955700 No abstract available.
• Macrolides in the treatment of asthma and cystic fibrosis.

  Ferrara G, Losi M, Franco F, Corbetta L, Fabbri LM, Richeldi L. Ferrara G, et al. Respir Med. 2005 Jan;99(1):1-10. doi: 10.1016/j.rmed.2004.09.014. Respir Med. 2005. PMID: 15672842 Review.